Reviewed by Peptide Treatments Medical Advisory Board (Medical Advisory Board)
AOD-9604: Bloodwork Guide
Recommended lab tests and biomarkers to monitor before, during, and after AOD-9604 therapy. Testing schedules are based on clinical protocols and published monitoring guidelines.
Back to AOD-9604 overviewBefore Starting (3 tests)
| Biomarker | Expected Effect | Retest |
|---|---|---|
| IGF-1 | → normalizes | Once (baseline) |
| Fasting Glucose | → normalizes | Once (baseline) |
| Lipid Panel | → normalizes | Once (baseline) |
During Treatment (3 tests)
| Biomarker | Expected Effect | Retest |
|---|---|---|
| Body Weight | ↓ decreases | Every 8 weeks |
| Visceral Fat | ↓ decreases | Every 8 weeks |
| Triglycerides | ↓ decreases | Every 12 weeks |